Innovation
2 patent families — focus: Human necessities; filing pace slowing. Cited 26 times.
| Year | Filings |
|---|---|
| 2021 | 2 |
| 2023 | 1 |
| 2024 | 1 |
Social engagement
Social engagement: 659 social following, 2 posts in the last 12 months — below the industry typical range.
Investor mix
3 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 67% |
| Other / undisclosed | 1 | 33% |
Recent activity
30 Jul 2025
Product launch
EM221, a next-generation PDE10A inhibitor